Login |

Sean M. Studer, MD, MSc
Chief of Medicine

NYU-Woodhull Medical Center
Brooklyn, New York

Get Adobe Flash player Install latest flash player if you can't see this gallery.

Clinical Focus

Pulmonary Medicine
  • Critical Care Medicine 
Professional Education

BS:  Biology, University of Notre Dame, South Bend, Indiana
MSc:  Clinical and Translational Research, University of Pittsburgh, Pittsburgh, Pennsylvania 
Medical Degree:  UMDNJ-New Jersey Medical School, Newark, New Jersey
Residency:  Internal Medicine, Medical College of Pennsylvania Hospital, Philadelphia, Pennsylvania
Fellowship:  Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland
Fellowship:  Pulmonary Hypertension / Lung Transplantation, Johns Hopkins Hospital, Baltimore, Maryland

Board Certification

Internal Medicine
Pulmonary Medicine
Critical Care Medicine

Clinical and Research Interests
  • Lung transplantation
  • Cystic fibrosis
  • Emphysema
  • Pulmonary fibrosis
Sean M. Studer, MD, MSc, prior to his current position at NYU-Woodhull Medical Center, served Newark Beth Israel Medical Center in the Pulmonary Division from 2008 to 2013 as Director of Lung Transplantation and Pulmonary Hypertension. Previously he served as Associate Director of the Pulmonary Hypertension Program and Director of the Pulmonary Transplant Medicine Fellowship at the University of Pittsburgh. Before that, Dr. Studer was Chief of Pulmonary Transplant Medicine at Mount Sinai Medical Center, New York, New York.

Dr. Studer is a principal investigator for numerous clinical research initiatives. In addition to being the author of many articles, book chapters and abstracts, he serves as a manuscript reviewer for several medical journals including the American Journal of Respiratory and Critical Care Medicine, Annals of Thoracic Surgery, Transplantation, and the Journal of Heart and Lung Transplant. He is an Editorial Board member for Advances in Pulmonary Hypertension and is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association. Dr. Studer lectures nationally and internationally on pulmonary hypertension, lung transplant and advanced lung diseases.

Dr. Studer completed fellowships in pulmonary and critical care as well as advanced lung disease at the Johns Hopkins Hospital, Baltimore, Maryland.  He is a Fellow of the American College of Chest Physicians and a member of the American Thoracic Society (ATS), the New Jersey Thoracic Society (NJTS), the International Society of Heart Lung Transplant (ISHLT).


Recent Publications

1: McMahon C, Studer SM, Clendinen C, Dann GP, Jeffrey PD, Hughson FM. The
structure of Sec12 implicates potassium ion coordination in Sar1 activation. J
Biol Chem. 2012 Dec 21;287(52):43599-606. doi: 10.1074/jbc.M112.420141. Epub 2012
Oct 29. PubMed PMID: 23109340; PubMed Central PMCID: PMC3527946.

2: Poor HD, Girgis R, Studer SM. World Health Organization Group III pulmonary
hypertension. Prog Cardiovasc Dis. 2012 Sep-Oct;55(2):119-27. doi:
10.1016/j.pcad.2012.08.003. Review. PubMed PMID: 23009908.

3: Shyu S, Dew MA, Pilewski JM, DeVito Dabbs AJ, Zaldonis DB, Studer SM, Crespo
MM, Toyoda Y, Bermudez CA, McCurry KR. Five-year outcomes with alemtuzumab
induction after lung transplantation. J Heart Lung Transplant. 2011
Jul;30(7):743-54. doi: 10.1016/j.healun.2011.01.714. Epub 2011 Mar 21. PubMed
PMID: 21420318; PubMed Central PMCID: PMC3110582.

4: Husain S, Capitano B, Corcoran T, Studer SM, Crespo M, Johnson B, Pilewski JM,
Shutt K, Pakstis DL, Zhang S, Carey ME, Paterson DL, McCurry KR, Venkataramanan
R. Intrapulmonary disposition of amphotericin B after aerosolized delivery of
amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
Transplantation. 2010 Dec 15;90(11):1215-9. doi: 10.1097/TP.0b013e3181f995ea.
PubMed PMID: 20881664.